The drug, “Deanxit”, was officially approved for use in India 14 years ago and has been on sale ever since. The drug is made by the Danish pharmaceutical company Lundbeck and distributed in India by its wholly owned subsidiary. In early 2011 the story that Deanxit was not licensed in Denmark was reported by MIMS and subsequently picked up by several leading Indian papers including the Times of India and the Financial Express.
Lundbeck responded by filing a criminal and civil libel case against MIMS and its editor Dr. Chandra M. Gulhati, as well as against the two newspapers, claiming damage to its reputation. MLDI is paying MIMS’s legal costs and has arranged for libel barrister Jonathan Crystal to advise the local lawyers on defending the case.
Meanwhile, the story itself has moved on.
In 2012 a parliamentary committee in India said the decision to allow use of the drug had been “illegal” and criticised the regulator — the Drugs Controller General of India (DCGI) — for approving it. Noting that the drug was not marketed in many developed countries such as the United States, Britain, Canada, Australia and Japan, the committee observed: “It is strange that the manufacturer is concentrating on tiny markets in unregulated or poorly-regulated developing countries ….. instead of countries with far more patients and profits.”
Recent News
The Supreme Court Upholds Torture Convictions in the Case of Claudia Julieta Duque
This article was originally published in Spanish by our partner Fundación para la Libertad de Prensa (FLIP). Read the original here. The Colombian Supreme Court has rejected appeals filed by Emiro Rojas Granados, the former Deputy Director of the redundant Colombian secret police – the Administrative Department of Security (DAS) – and Néstor Javier Pachón […]
Ariane Lavrilleux: Landmark Judgment for Source Protection to be Appealed by Paris Public Prosecutor
On 9 October 2025, the Paris Criminal Court dismissed the proceedings against French investigative journalist Ariane Lavrilleux in the Egypt Papers case. During the hearing, the judge also reportedly recognised the public interest of the 2021 Egypt Papers investigation, co-authored by Lavrilleux for the independent outlet Disclose. The investigation exposed a covert French intelligence operation, known as Operation Sirli, in Egypt and alleged French complicity […]
Press Freedom Advocates: Tornavoz’s Charlene Nagae on Journalism, Lawsuits and Solidarity in Brazil
In this edition of Press Freedom Advocates, Media Defence’s Communications Officer, Anoushka Schellekens, speaks with Charlene Miwa Nagae, Co-founder of Tornavoz, about the landscape, the threats, and how legal support and strategic litigation are key to ensuring this promising new wave of journalism can endure.